Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine for cardiac function in chronic heart failure with subclinical hypothyroidism
2010-020540-34Phase 4Active
- Sponsor
- Policlinico di Bari
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levothyroxine sodium in hypothyroidism and chronic heart failure (CHF) (2 arms), sponsored by Policlinico di Bari. Primary endpoint: Left ventricular ejection fraction. Started Sep 2010; status: active.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidismchronic heart failure (CHF)
Beyond the preview
Go deeper on 2010-020540-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020540-34.